Clinical Trial Update: Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients [Phase 1]

View source ↗

Summary

Phase 1 safety and feasibility study evaluating autologous bone marrow mononuclear cells in ischemic stroke patients has completed and results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Autologous bone marrow mononuclear cells (bone marrow mononuclear cells)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Ischemic Stroke | Phase 1 | Status: COMPLETED | Results posted: 2015-01-01